By the Peptides Lab Ireland research team · Updated July 2026 · Research-context information only
“Is BPC-157 legal in Ireland?” is one of the most-searched questions in the Irish peptide research space. The answer depends entirely on what BPC-157 is being sold as and who is buying it. This guide sets out the distinction the Health Products Regulatory Authority (HPRA) actually makes.
The short answer
BPC-157 as a research chemical for in-vitro laboratory research : supplied with a Certificate of Analysis, labelled “not for human or veterinary use”, and purchased by a researcher or research institution for scientific work — is outside the medicines authorisation regime and is supplied under research chemical frameworks in Ireland.
BPC-157 as a medicinal product , marketed with therapeutic claims, dosing schedules for humans, before/after imagery, or clinical use language , with isn’t authorised in Ireland. It hasn’t been evaluated or approved by the HPRA or the European Medicines Agency (EMA) for human therapeutic use, and supplying it as a medicine is an HPRA enforcement target.
These are two entirely different regulatory conversations. Sellers who blur the line create legal exposure for themselves and for buyers who are misled.
What BPC-157 actually is
BPC-157 (Body Protection Compound 157) is a synthetic 15 amino acid pentadecapeptide (sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, molecular weight ≈ 1419.5 Da). It is a stable partial sequence of a protein present in human gastric juice. It has an extensive preclinical research literature base spanning tendon repair, gastrointestinal barrier function, angiogenesis and other tissue-repair mechanisms. See our BPC-157 research reference for the technical detail.
The regulatory framework in Ireland
Ireland’s medicines legislation defines a “medicinal product” as any substance presented as having properties for treating or preventing disease, or that has that effect pharmacologically in humans. The HPRA regulates medicinal products. It does not regulate research chemicals supplied for in-vitro laboratory research.
BPC-157 hasn’t received a marketing authorisation from either the HPRA or the EMA. That means:
- Selling BPC-157 as a medicinal product in Ireland and with therapeutic claims, human dosing guidance or clinical language , is unauthorised medicinal product supply. This is an offence under the Irish Medicinal Products (Control of Manufacture) Regulations.
- Selling BPC-157 as a research chemical, clearly labelled for laboratory research use only, isn’t covered by the medicines regime. It’s supplied under research chemical / laboratory supply frameworks.
How the HPRA decides which category a supplier is in
HPRA enforcement actions in this space look at how the product is presented. Marks of an unauthorised medicinal product supply include:
- Therapeutic claims: “helps healing”, “treats injuries”, “supports recovery” written for humans
- Human dosing schedules: “take 250 mcg twice daily”, injection guides, cycle protocols
- Before/after imagery or testimonials
- Marketing to end users (rather than research laboratories)
- Retail-style packaging without research-only labelling
Marks of legitimate research chemical supply include:
- Product page describes preclinical research applications, not therapeutic effects
- Every vial labelled “For laboratory research use only and not for human or veterinary use”
- Per-batch Certificates of Analysis (see our COA guide)
- Customs paperwork accurately declares research chemicals for in-vitro use
- Sold to laboratories, research groups and identifiable researchers
What buyers should check
Before buying BPC-157 in Ireland from any supplier:
- Does the product page describe research applications, not therapeutic effects?
- Is the vial labelled “For laboratory research use only — not for human or veterinary use”?
- Is a batch-specific Certificate of Analysis provided with the order?
- Does the supplier explicitly state a research-only supply model, or do they push human-use language?
If any of those come back “no”, you’re dealing with an unauthorised medicinal product supplier and both parties are at risk under Irish medicines legislation.
Importation into Ireland
Post-Brexit, BPC-157 shipped from Great Britain to Ireland crosses a customs border. Customs paperwork should declare the goods as research chemicals for in-vitro use, with the correct commodity code and “not for human use” statement. Misdeclaration by a supplier (e.g. describing peptides as cosmetics or food supplements) transfers compliance risk to the buyer.
What Peptides Lab Ireland’s supply model looks like
- Product pages describe research applications and preclinical research literature — not therapeutic effects
- Every vial labelled “For laboratory research use only not for human or veterinary use”
- Every batch has an independent Certificate of Analysis from Optima Labs
- Customs paperwork accurately declares research chemicals for research use
- No before/after imagery, no human dosing schedules, no treatment claims
Full regulatory context: see our HPRA and Research Peptides in Ireland guide.
Frequently asked
Can I get BPC-157 from a pharmacy in Ireland?
No. There is no HPRA-authorised BPC-157 medicinal product. Pharmacies dispense authorised medicines only.
Can a doctor prescribe BPC-157 in Ireland?
No. There is no authorised medicinal product to prescribe. A doctor can’t lawfully prescribe an unauthorised medicine except in narrow named-patient contexts, which don’t apply to research peptides in the current framework.
What happens if the HPRA investigates a supplier?
Enforcement outcomes range from warning letters and product seizures to prosecution for unauthorised medicinal product supply. The Irish Examiner has reported multi-hundred-thousand-unit seizures of illicit weight-loss compounds under this framework in the past 18 months.
Is BPC-157 legal for research at Irish universities?
Research use of research chemicals in Irish universities operates under institutional research protocols, procurement rules, and applicable health-and-safety frameworks , not under medicines regulation. Peptides Lab Ireland supplies institutional research accounts.
Further reading
- HPRA Regulations and Research Peptides in Ireland
- Are Peptides Legal in Ireland?
- BPC-157 Ireland and Research Reference
- How to Read a Peptide COA
- Official: HPRA
Ireland & EU regulatory framework
What we supply is research-grade, research-only material. Under Irish medicines legislation and the HPRA framework, these compounds aren’t authorised as medicinal products, and they aren’t intended for human or veterinary use. If you find inaccuracies in a research reference like this, tell us and we’ll correct it. This article gives research context, not medical or dosing advice.